Company roundup

  • Updated: March 15, 2013 - 7:53 PM
  • share

    email

NEW PRODUCTS

Cardiovascular Systems Inc., St. Paul, has submitted its premarket approval application to the U.S. Food and Drug Administration for its orbital atherectomy system, used to treat calcified coronary arteries.

  • get related content delivered to your inbox

  • manage my email subscriptions
  • share

    email

ADVERTISEMENT

Connect with twitterConnect with facebookConnect with Google+Connect with PinterestConnect with PinterestConnect with RssfeedConnect with email newsletters

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

 
Close